Viewing Study NCT00424203


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2025-12-29 @ 12:59 AM
Study NCT ID: NCT00424203
Status: COMPLETED
Last Update Posted: 2013-09-04
First Post: 2007-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
Sponsor: UNICANCER
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CDR0000523419
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators